Skip to content

STRETTA ,Radio Frequency Ablation (RFA) v/s Sham Therapy for the Treatment of Refractory GERD

A Prospective Randomized Trial Comparing Endoscopic Radio Frequency Ablation (RFA) - STRETTA vs Sham Therapy for the Treatment of Refractory Gastroesophageal Reflux Disease

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02935881
Acronym
STRETTAGERD
Enrollment
20
Registered
2016-10-18
Start date
2015-01-31
Completion date
2017-01-31
Last updated
2016-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Brief summary

Gastro-esophageal reflux disease (GERD) is a chronic disorder with significant impact on the quality of life of patients. It may also lead to several complications like peptic strictures, ulcerations, Barrett 's disease and subsequently adenocarcinoma of the esophagus. Proton pump inhibitors (PPIs) are the mainstay of GERD treatment, with up to 90 % of patients with reflux disease becoming asymptomatic while taking PPIs. Several studies have demonstrated that RF delivery at the gastro-esophageal junction(GEJ), also called the Stretta procedure, induces symptom relief and decreases need of PPI intake in GERD. The investigators propose to perform a sham-controlled randomized study to evaluate the influence of the Stretta procedure on symptoms and esophageal acid exposure in patients of refractory GERD.

Detailed description

Gastro-esophageal reflux disease (GERD) is a chronic disorder with significant impact on the quality of life of patients. It may also lead to several complications like peptic strictures, ulcerations, Barrett 's disease and subsequently adenocarcinoma of the esophagus. Proton pump inhibitors (PPIs) are the mainstay of GERD treatment, with up to 90 % of patients with reflux disease becoming asymptomatic while taking PPIs. However, the treatment of patients with proven GERD, who have an unsatisfactory response to high doses of PPIs remains a challenge. A number of endoscopic procedures, aimed at improvement of the barrier function of the lower esophageal sphincter (LES), have emerged over the last decade. Several studies have demonstrated that RF delivery at the gastro-esophageal junction(GEJ), also called the Stretta procedure, induces symptom relief and decreases need of PPI intake in GERD. The investigators propose to perform a sham-controlled randomized study to evaluate the influence of the Stretta procedure on symptoms and esophageal acid exposure in patients of refractory GERD.

Interventions

DEVICERadio Frequency Ablation (RFA) (Stretta Procedure)

Radio Frequency Ablation (RFA) for the treatment of refractory gastroesophageal reflux disease.

PROCEDURESham Procedure

Stretta device will be used but Radio Frequency Ablation (RFA) will not be generated.

Sponsors

Asian Institute of Gastroenterology, India
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18years * Small hiatus hernia (\< 2-3 cm) * Los Angeles Grade 'A' or 'B' Reflux Esophagitis * LES pressure : 5 - 15 mm Hg * PPI dependent / refractory GERD * 24 hr acid exposure study showing abnormal esophageal acid exposure \> 4% * DeMeester Score \>14.7 * Esophageal manometry showing normal peristalsis

Exclusion criteria

* Age \< 18 years * Large hiatus hernia (\> 3 cm) * Los Angeles Grade 'C' or 'D' Reflux Esophagitis * LES pressure : \< 5 or \> 15 mm Hg * Underlying coagulation disorder * Previous Esophageal or Gastric surgery * H/o coronary artery disease (CAD) * Esophageal manometry showing ineffective peristalsis

Design outcomes

Primary

MeasureTime frameDescription
Number of patients who report improvement in Quality of Life (QOL) post Stretta procedure as compared to Sham therapy.1 year6 point GERD Likert Scale will be used to assess the improvement in frequency and severity of GERD symptoms post Stretta procedure & Sham therapy amongst patients.

Secondary

MeasureTime frameDescription
Number of patients who report independence from Proton Pump Inhibitor (PPI) drug post Stretta procedure as compared to Sham therapy.1 yearQuestionnaire will be provided to each participant to report no further requirement of PPI drug post procedure.
Comparison of Increased Lower Esophageal Sphincter pressure among patients post Stretta procedure & Sham Therapy.1 yearHigh Resolution Esophageal Manometry will be performed after the procedure in each patient to compare the LES pressure between the two groups.

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026